Europe Readies For Big Changes In Device Post-Market Surveillance
This article was originally published in SRA
Efforts to strengthen post-market surveillance activities for medical devices in the EU are picking up steam as the region tries to address gaps identified in the wake of the Poly Implant Prothèse (PIP) affair.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies